Stock data
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO) reported revenue of US$0.50M and net income of -US$41.88M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.50M | — | -US$40.11M | -US$41.88M | — |
| 2024 | US$0.00M | — | -US$47.36M | -US$43.25M | — |
| 2023 | US$10.00M | — | -US$28.42M | -US$29.47M | — |
| 2022 | US$0.00M | — | -US$54.43M | -US$42.22M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$7.00M | — |
| 2026-03-31 | — | -US$6.72M | — |
| 2025-12-31 | — | -US$7.35M | — |
| 2025-09-30 | US$0.00M | -US$7.02M | — |
| 2025-06-30 | US$0.50M | -US$14.62M | — |
| 2025-03-31 | — | -US$12.89M | — |
| 2024-12-31 | US$0.00M | -US$7.05M | — |
| 2024-09-30 | US$0.00M | -US$15.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.